Receptos to Hold First Quarter 2014 Financial Results Conference Call and Webcast
07 May 2014 - 10:00PM
Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company
developing therapeutic candidates for the treatment of immune and
metabolic diseases, will announce financial results for the first
quarter ended March 31, 2014 on Monday, May 12 before the markets
open. The announcement will be followed by a live webcast and
conference call at 8:30 a.m. Eastern time (5:30 a.m. Pacific
time).
Receptos management will host the call and webcast to discuss
financial results and recent business highlights. The live
call may be accessed by phone by calling (866) 757-6808 (domestic)
or (760) 536-5211 (international), conference ID 32184280. The
webcast can be accessed live on the Investor Relations section of
the Receptos website at www.receptos.com and will be archived for
14 days following the call. A replay of the call will be
available by phone by calling (855) 859-2056 or (404) 537-3406,
conference ID 32184280.
About Receptos
Receptos is a biopharmaceutical company developing therapeutic
candidates for the treatment of immune and metabolic diseases. The
Company's lead program, RPC1063, is a sphingosine 1-phosphate 1
receptor (S1P1R) small molecule modulator candidate for immune
indications, including relapsing multiple sclerosis (RMS) and
inflammatory bowel disease (IBD). The Company is also developing
RPC4046, an anti-interleukin-13 (IL-13) antibody for an
allergic/immune-mediated orphan disease, eosinophilic esophagitis
(EoE). Receptos has established expertise in high resolution
protein crystal structure determination, biology and drug discovery
for G-protein-coupled receptors (GPCRs).
CONTACT: Media and Investor Contact:
Graham K. Cooper
Chief Financial Officer, Receptos
(858) 652-5708
gcooper@receptos.com
Michael Rice
Founding Partner
LifeSci Advisors, LLC
(646) 597-6979
mrice@lifesciadvisors.com
RECEPTOS, INC. (NASDAQ:RCPT)
Historical Stock Chart
From Jun 2024 to Jul 2024
RECEPTOS, INC. (NASDAQ:RCPT)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More News Articles